Sheba Medical Center to Integrate Elbit Systems Advanced Military Thermal Imaging Technology

Sheba Medical Center, Israel’s largest medical center and a Newsweek top-10 ranked world’s best hospital for the last four years, announced today that is has signed a Memorandum of Understanding (MoU) with Opgal, a subsidiary of Elbit Systems, to utilize advanced thermal imaging technologies previously used for military and security purposes. The integration of the thermal imaging cameras intends to improve the efficiency and efficacy of surgery and treatment in four key areas: heart surgery, diabetic foot treatment, surgical incision infections and respiratory monitoring.

Thermal photography, best known for its role in the world of defense and aerospace, offers significant potential for healthcare. Using thermal cameras, physicians can detect physiological processes based on changes in energy and heat in the body and display these changes on a digital screen. Used in the medical setting, this technology can enable doctors and surgeons to accurately identify the movement of blood vessels and present a clear picture of carbon dioxide being emitted by exhalation.

“The new relationship between medical excellence and excellence in the defense industry is groundbreaking,” said Prof. Eyal Zimlichman, Sheba’s chief innovation and transformation officer, and head of ARC. “The solutions worked on by Elbit and Opgal experts and Sheba doctors are not only significant for Sheba and Israel but will have an international impact. These are global solutions to global problems, and we believe there is great potential here to change the face of medicine on an international level.”

Using these new technological developments, Sheba medical teams will be able to receive previously unavailable new information in real time, for the purpose of formulating increasingly accurate medical diagnoses. The photographed materials will also be analyzed at Sheba using artificial intelligence tools and will enter a computerized database for future use by doctors in decision making.

Sheba Medical Center is leading the digital transformation to advanced digital medicine in Israel and around the world. Sheba, through its innovation arm, ARC (Accelerate, Redesign, Collaborate), is building and maintaining close collaborations and projects with the world’s best hospitals and leading companies in the industry, such as the one with Opgal and Elbit Systems.

“Thermal technology, which until now has helped pilots take off and land, and soldiers on the battlefield identify threats and targets, has the potential to help medical teams worldwide to see the invisible and make more accurate diagnoses,” said Tsachi Israel, CEO of Opgal. “We are the leading experts in our respective fields, working together to innovate in order to save lives and prevent suffering for many patients.”

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.